{"id":174042,"title":"Notice to Stakeholders - Policy Statement on the Naming of Biologic Drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T16:03:08.795000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-notice-to-stakeholders-drugs-naming-of-biologics.html?wbdisable=true","snippet":"Notice to Stakeholders - Policy Statement on the Naming of Biologic Drugs - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main Menu Jobs and the workplace Immigration and…","rawSnapshotUrl":"/api/snapshots/raw/174042","browseUrl":"https://replay.healtharchive.ca/job-1/20250418160308/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-notice-to-stakeholders-drugs-naming-of-biologics.html?wbdisable=true#ha_snapshot=174042","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}